Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ambrilia, ZBx Enter Licensing Deal | Contract Pharma

What are you searching for?

Sign in
Breaking News

Ambrilia, ZBx Enter Licensing Deal

Ambrilia has entered into an agreement granting ZBx Corp. an option to acquire exclusive worldwide rights to Ambrilia's PSP-94 reagents and related intellectual property.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Ambrilia has entered into an agreement granting ZBx Corp. an option to acquire exclusive worldwide rights to Ambrilia’s PSP-94 reagents and related intellectual property. If ZBx exercises its option, Ambrilia would be eligible to receive as much as $50,000 upfront, sales milestones, royalties on sales, as well as a percentage of proceeds from any sublicenses or sale of PSP-94. ZBx will cover further development, manufacturing and commercialization costs.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters